Details for: CL0002048

Cell ID: CL0002048

Cell Name: late pro-B cell

Description: Late pro-B cells are also reportedly CD10-positive, CD20-negative, CD21-negative, and TdT-positive. Transcription factors: PU.1-positive, Ikaros-positive, E2A-positive, and PAX5-positive.

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for late pro-B cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for late pro-B cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for late pro-B cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for late pro-B cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  late pro-B cell (CL0002048)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [late pro-B cell](/details-cell/CL0002048) is an early B-lymphocyte progenitor, characterized by the expression of transcription factors such as PAX5 and surface markers including CD10. Based on gene significance analysis, this cell type exhibits a molecular signature of intense metabolic, transcriptional, and translational activity, consistent with its role as a rapidly proliferating and differentiating cell. The high specificity score (`csi_z`) for genes involved in chromatin structure ([H3 3B](/details-gene/3021)), glycolysis ([GAPDH](/details-gene/2597)), and RNA processing ([HNRNPA1](/details-gene/3178)) underscores the fundamental housekeeping processes that define this cell's state. Crucially, the specific expression of [IGLL1](/details-gene/3543), a component of the pre-B cell receptor surrogate light chain, confirms its identity and commitment to the B cell lineage at this critical developmental checkpoint. ## Key Characteristics and Function Analysis of gene significance within the **Overall** context reveals several core functional clusters that define the [late pro-B cell](/details-cell/CL0002048). The `csi_z` metric, which highlights expression specificity, points to genes whose unique expression levels are characteristic of this cell type. * **B-Cell Lineage Commitment and Signaling:** The most definitive B-lineage marker with a high specificity score is [IGLL1](/details-gene/3543) (CSI: 33.14). This gene encodes a component of the surrogate light chain, which combines with the immunoglobulin heavy chain to form the pre-B cell receptor (pre-BCR). Signaling through the pre-BCR is a crucial checkpoint for B cell development, promoting survival, proliferation, and differentiation to the pre-B cell stage. * **High Metabolic Activity:** A prominent feature is the high significance of genes involved in core metabolic processes. This includes [GAPDH](/details-gene/2597) (CSI: 39.03), a key glycolytic enzyme, and multiple subunits of the mitochondrial ATP synthase complex such as [ATP5MC2](/details-gene/517) (CSI: 33.65) and [ATP5MG](/details-gene/10632) (CSI: 33.54). This signature suggests a high energy demand required to fuel the rapid cell division and biosynthetic processes inherent to this progenitor stage. * **Robust Transcriptional and Post-Transcriptional Regulation:** A large number of top markers are involved in RNA processing. These include heterogeneous nuclear ribonucleoproteins like [HNRNPA1](/details-gene/3178) (CSI: 37.13) and [HNRNPA2B1](/details-gene/3181) (CSI: 35.80), which regulate mRNA splicing and transport, as well as RNA-binding proteins like [PCBP2](/details-gene/5094) (CSI: 37.42) and the poly(A)-binding protein [PABPC1](/details-gene/26986) (CSI: 34.88). This indicates a highly active and regulated system for gene expression, which is essential for executing the complex differentiation program. * **Cell Cycle Progression and Chromatin Dynamics:** The top marker, [H3 3B](/details-gene/3021) (CSI: 40.18), along with [H3 3A](/details-gene/3020) (CSI: 35.93), are histone H3.3 variants associated with transcriptionally active chromatin. The high score for [CCNI](/details-gene/10983) (CSI: 37.81), a G1/S cyclin, directly points to active cell cycle progression. Furthermore, genes like [HMGB1](/details-gene/3146) (CSI: 37.58) and [NPM1](/details-gene/4869) (CSI: 32.05) are crucial for chromatin architecture, DNA repair, and ribosome biogenesis, reinforcing the cell's proliferative nature. ## Clinical Significance and Contextual Roles The gene signature of the [late pro-B cell](/details-cell/CL0002048) provides insight into its potential role in hematological malignancies. The intense proliferative and metabolic state, governed by the precise regulation of the cell cycle and gene expression, represents a developmental stage vulnerable to oncogenic transformation. The machinery that drives normal pro-B cell expansion is often hijacked in B-cell acute lymphoblastic leukemia (B-ALL). The specific expression of [IGLL1](/details-gene/3543) is used as a diagnostic marker for certain subtypes of B-ALL that are arrested at this developmental stage. Furthermore, the high activity of genes involved in RNA processing and chromatin regulation, such as [HNRNPA1](/details-gene/3178) and [NPM1](/details-gene/4869), suggests that dysregulation of these fundamental processes could contribute to leukemogenesis. Mutations in [NPM1](/details-gene/4869) are a known driver in acute myeloid leukemia, and its prominent role in this B-cell progenitor highlights its broader importance in hematopoietic stem and progenitor cell biology. The metabolic profile, marked by high glycolytic activity ([GAPDH](/details-gene/2597)), is also a hallmark of many cancers (the Warburg effect). This suggests that the metabolic wiring of [late pro-B cells](/details-cell/CL0002048) may make them particularly susceptible to mutations that further enhance this state, providing a survival and proliferative advantage that can lead to malignant outgrowth. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The highly specific expression of a suite of RNA-binding proteins (e.g., [HNRNPA1](/details-gene/3178), [PCBP2](/details-gene/5094)) and chromatin regulators ([HMGB1](/details-gene/3146)) in [late pro-B cells](/details-cell/CL0002048) establishes a unique regulatory network. This network coordinates a specific alternative splicing and transcriptional program required for executing the developmental checkpoint associated with pre-BCR signaling. * **Surprising Findings:** It is remarkable that ubiquitously expressed RNA-binding proteins show such high cell-type specificity based on the `csi_z` score. This suggests that their expression levels are quantitatively unique in [late pro-B cells](/details-cell/CL0002048) compared to other hematopoietic cells, implying a specialized, context-dependent function beyond general housekeeping. * **Testable Questions:** Does CRISPR-mediated depletion of [HNRNPA1](/details-gene/3178) in a human pro-B cell line (e.g., NALM-6) lead to specific changes in the splicing patterns of key B-cell transcription factors like PAX5 or genes downstream of pre-BCR signaling? 2. **Hypothesis:** The high glycolytic rate, indicated by the prominent specificity of [GAPDH](/details-gene/2597), is not merely a byproduct of proliferation but is actively coupled to the [IGLL1](/details-gene/3543)-dependent pre-BCR checkpoint. Successful signaling through the pre-BCR may induce a metabolic reprogramming switch that is essential to fuel the subsequent clonal expansion and differentiation of the cell. * **Surprising Findings:** The identification of [GAPDH](/details-gene/2597), a canonical housekeeping gene, as a top-ranked specific marker (rCSI 97.8%) is unexpected. This may point towards non-canonical, or "moonlighting," functions for GAPDH in this cell type, potentially involving roles in signal transduction or apoptosis regulation that are critical at this developmental stage. * **Testable Questions:** Using a pro-B cell culture model, can pre-BCR cross-linking induce a rapid increase in glucose uptake and lactate production? Furthermore, is this metabolic shift dependent on key signaling intermediates like PI3K/Akt and can it be blocked by inhibitors of glycolysis, leading to cell cycle arrest or apoptosis?